The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions

K Montet-Abou; M Viallon; J-N Hyacinthe; B Delattre; J-P Vallee; D Didier; P Croisille; X Montet

doi:10.1038/ijo.2010.242

The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions

Int J Obes (Lond). 2010 Dec:34 Suppl 2:S67-81. doi: 10.1038/ijo.2010.242.

Authors

K Montet-Abou¹, M Viallon, J-N Hyacinthe, B Delattre, J-P Vallee, D Didier, P Croisille, X Montet

Affiliation

¹ Department of Radiology, Geneva University Hospital, Geneva, Switzerland.

PMID: 21151150
DOI: 10.1038/ijo.2010.242

Abstract

Despite intense effort, obesity is still rising throughout the world. Links between obesity and cardiovascular diseases are now well established. Most of the cardiovascular changes related to obesity can be followed by magnetic resonance imaging (MRI) or by magnetic resonance spectroscopy (MRS). In particular, we will see in this review that MRI/MRS is extremely well suited to depict (1) changes in cardiac mass and function, (2) changes in stroke volume, (3) accumulation of fat inside the mediastinum or even inside the cardiomyocytes, (4) cell viability and (5) molecular changes during early cardiovascular diseases.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Cardiovascular Diseases / diagnosis*
Cardiovascular Diseases / physiopathology
Early Diagnosis
Female
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Metabolic Syndrome / diagnosis*
Metabolic Syndrome / physiopathology
Obesity / complications*
Obesity / physiopathology